Previous 10 | Next 10 |
2023-11-12 04:19:02 ET RxSight, Inc. (RXST) Q3 2023 Earnings Conference Call November 09, 2023, 04:30 PM ET Company Participants Alex Huang - Director, Investor Relations Ron Kurtz - President and Chief Executive Officer Shelley Thunen - Chief Financial Officer ...
2023-11-09 16:41:24 ET More on RxSight RxSight: Losing Altitude Despite 'Best Of Breed' Platform RxSight: Poised To Make Waves In Ophthalmic Market Seeking Alpha’s Quant Rating on RxSight Historical earnings data for RxSight Financial informati...
ALISO VIEJO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three and nine months ...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
RxSight Inc. (RXST) is expected to report $-0.42 for Q3 2023
ALISO VIEJO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- November 2, 2023 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced educational opportunities and product updates at t...
2023-10-27 11:12:40 ET Summary Today we look at RxSight, Inc., a small ocular focused medical device company focused on transforming the cataract surgery market. The company is delivering 70% year-over-year revenue growth and rapidly expanding its installed base. After a big r...
ALISO VIEJO, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the third ...
2023-10-23 11:52:25 ET Summary Small-cap tech stocks have been overshadowed by mega-cap tech giants despite their potential for innovation and future growth. Smaller-cap stocks have appeal for potential acquisition by larger corporations. Three small cap tech stocks focused on...
2023-08-16 02:57:08 ET Summary RxSight's Q2 2023 earnings showed an 83% increase in revenue, driven by growth in LDD and LAL earnings. The company has a healthy liquidity position with $147.1M in liquid assets and a reduced term loan liability. Despite ongoing operational loss...
News, Short Squeeze, Breakout and More Instantly...
ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second...
ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference. ...
Shareholders approved all agenda items and proposals of the Board of Directors Robert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of Directors Baruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D. appointed as members of th...